[1] Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs—the micro steering wheel of tumour metastases[J]. Nat Rev Cancer, 2009, 9(4):293-302.
[2] Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy[J]. Circ Res, 2007, 100(3):416-424.
[3] Carè A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy[J]. Nat Med, 2007, 13(5):613-618.
[4] Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2[J]. Cell, 2007, 129(2):303-317.
[5] 张荣, 董德利, 杨宝峰. 心律失常调节的新靶点——microRNA的研究进展与应用前景[J]. 药学学报, 2011, 46(1):6-11.
[6] 张莹, 张勇, 蔡本志, 等. microRNA在犬心房纤颤模型中的变化[J]. 哈尔滨医科大学学报, 2007, 41(2):92-94.
[7] Weigel D, Jackle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?[J]. Cell, 1990, 63(3):455-456.
[8] Katoh M, Katoh M. Human FOX gene family(Review)[J]. Int J Oncol, 2004, 25(5):1495-1500.
[9] Wang B, Weidenfeld J, Lu MM, et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation[J]. Development, 2004, 131(18):4477-4487.
[10] Lagos-quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse[J]. Curr Biol, 2002, 12(9):735-739.
[11] Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury[J]. Clin Chem, 2009, 55(11):1944-1949.
[12] Navickas R, Gal D, Laucevicius A, et al. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review[J]. Cardiovasc Res, 2016, 111(4):322-337.
[13] Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction[J]. J Biol Chem, 2009, 284(43):29514-29525.
[14] Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20[J]. Circulation, 2009, 119(17):2357-2366.
[15] Wang L, Yuan Y, Li J, et al. MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network[J]. Cell Stress Chaperones, 2015, 20(3):411-420.
[16] Zhu J, Yao K, Wang Q, et al. Ischemic postconditioning-regulated miR-499 protects the rat heart against ischemia/reperfusion injury by inhibiting apoptosis through PDCD4[J]. Cell Physiol Biochem, 2016, 39(6):2364-2380.
[17] Tian J, An X, Niu L. Role of microRNAs in cardiac development and disease[J]. Exp Ther Med, 2017, 13(1):3-8.
[18] Kim JE, Jung HJ, Lee YJ, et al. Vasopressin-regulated miRNAs and AQP2-targeting miRNAs in kidney collecting duct cells[J]. Am J Physiol Renal Physiol, 2015, 308(7):F749-F764.
[19] 姜文, 杨琴, 李新枝, 等. FOXP1在肿瘤演进中的研究进展[J]. 四川解剖学杂志, 2010, 18(3):38-40.
[20] 胡成如, 王靖华. FOXP1在肿瘤发生和发展中的作用[J]. 临床肿瘤学杂志, 2011, 16(11):1052-1055.
[21] Chanh SW, Mislankar M, Misra C, et al. Genetic abnormalities in FOXP1 are associated with congenital heart defects[J]. Hum Mutat, 2013, 34(9):1226-1230.